Crossmark

Cost-effectiveness of the withdrawal of treatment with inhaled colistin in patients with adult bronchiectasis not due to cystic fibrosis colonized by Pseudomonas aeruginosa

Crossref DOI link: https://doi.org/10.1016/j.medcle.2018.11.037

Published Print: 2020-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lera Álvarez, Rubén

Martínez Moragón, Eva

Suárez Varela, María Morales
License Information

Text and Data Mining valid from 2020-04-01
More Information

This article is maintained by: Elsevier

Article Title: Cost-effectiveness of the withdrawal of treatment with inhaled colistin in patients with adult bronchiectasis not due to cystic fibrosis colonized by Pseudomonas aeruginosa

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2018.11.037

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2018.11.008

Content Type: simple-article

Copyright: © 2018 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below